Tumor necrosis factor-alpha inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis.
Bosello
Silvia
S
De Santis
Maria
M
Tolusso
Barbara
B
Zoli
Angelo
A
Ferraccioli
Gianfranco
G
D001168:Arthritis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D009363:Neoplasm Proteins / Q000627:therapeutic use*; D047889:Receptors, Tumor Necrosis Factor, Type II / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000150:complications*; D053319:Tumor Necrosis Factor Decoy Receptors
D009363:Neoplasm Proteins; D047889:Receptors, Tumor Necrosis Factor, Type II; D053319:Tumor Necrosis Factor Decoy Receptors